These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10997795)

  • 1. Lack of association between the angiotensin-converting enzyme insertion/deletion polymorphism and plasminogen activator inhibitor-1 antigen levels in the National Heart, Lung, and Blood Institute Family Heart Study.
    Pankow JS; Arnett DK; Borecki IB; Hunt SC; Eckfeldt JH; Folsom AR; Djoussé L
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):551-8. PubMed ID: 10997795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1.
    Kim DK; Kim JW; Kim S; Gwon HC; Ryu JC; Huh JE; Choo JA; Choi Y; Rhee CH; Lee WR
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3242-7. PubMed ID: 9409318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme insertion/deletion polymorphism is associated with plasma antigen levels of plasminogen activator inhibitor-1 in healthy Japanese population.
    Matsubara Y; Hayakawa T; Tsuda T; Takeshita E; Watanabe G; Murata M; Watanabe K; Ikeda Y
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):115-20. PubMed ID: 10759003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 and angiotensin I converting enzyme gene polymorphism in patients with hypertension.
    Jeng JR; Harn HJ; Yueh KC; Jeng CY; Shieh SM
    Am J Hypertens; 1998 Feb; 11(2):235-9. PubMed ID: 9524054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
    Margaglione M; Grandone E; Vecchione G; Cappucci G; Giuliani N; Colaizzo D; Celentano E; Panico S; Di Minno G
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2082-7. PubMed ID: 9351375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians.
    Nagi DK; Foy CA; Mohamed-Ali V; Yudkin JS; Grant PJ; Knowler WC
    Metabolism; 1998 May; 47(5):622-6. PubMed ID: 9591757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease.
    Viitanen L; Pihlajamäki J; Halonen P; Lehtonen M; Kareinen A; Lehto S; Laakso M
    Atherosclerosis; 2001 Jul; 157(1):57-64. PubMed ID: 11427204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance?
    Panahloo A; Andrès C; Mohamed-Ali V; Gould MM; Talmud P; Humphries SE; Yudkin JS
    Circulation; 1995 Dec; 92(12):3390-3. PubMed ID: 8521557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
    Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
    Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants.
    Margaglione M; Cappucci G; d'Addedda M; Colaizzo D; Giuliani N; Vecchione G; Mascolo G; Grandone E; Di Minno G
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):562-7. PubMed ID: 9555861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype combinations of plasminogen activator inhibitor-1 and angiotensin-converting enzyme genes and risk for early onset of coronary heart disease.
    Loew M; Hoffmann MM; Hahmann H; Maerz W; Brenner H; Rothenbacher D
    Eur J Cardiovasc Prev Rehabil; 2006 Jun; 13(3):449-56. PubMed ID: 16926677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin I-converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort.
    Heijmans BT; Westendorp RG; Knook DL; Kluft C; Slagboom PE
    J Am Coll Cardiol; 1999 Oct; 34(4):1176-83. PubMed ID: 10520809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between plasma t-PA and PAI-1 levels is dependent on epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms.
    Moore JH; Smolkin ME; Lamb JM; Brown NJ; Vaughan DE
    Clin Genet; 2002 Jul; 62(1):53-9. PubMed ID: 12123488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.
    Jastrzebskal M; Widecka K; Naruszewicz M; Ciechanowicz A; Janczak-Bazan A; Foltynska A; Goracy I; Chetstowski K; Wesotowska T
    Nutr Metab Cardiovasc Dis; 2004 Oct; 14(5):259-69. PubMed ID: 15673060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis.
    de Carvalho SS; Simões e Silva AC; Sabino Ade P; Evangelista FC; Gomes KB; Dusse LM; Rios DR
    PLoS One; 2016; 11(3):e0150613. PubMed ID: 27022914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin I-converting enzyme gene polymorphism enhances the effect of hypercholesterolemia on the risk of coronary heart disease in a general Japanese population: the hisayama study.
    Kondo H; Ninomiya T; Hata J; Hirakawa Y; Yonemoto K; Arima H; Nagata M; Tsuruya K; Kitazono T; Kiyohara Y
    J Atheroscler Thromb; 2015; 22(4):390-403. PubMed ID: 25342476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of angiotensin I-converting enzyme gene polymorphism with ACE and PAI-1 levels in Guangdong Chinese Han patients with essential hypertension].
    Zhang YL; Zhou SX; Lei J; Zhang JM
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1681-4. PubMed ID: 18024289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.